Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Gianluca, Sottilotta"'
Publikováno v:
Jornal de Assistência Farmacêutica e Farmacoeconomia, Vol 1, Iss s1 (2023)
Com objetivo de avaliar as emoções e comportamentos dos adultos brasileiros com hemofilia durante o 1º ano da pandemia, a ABRAPHEM realizou uma pesquisa online com 17 perguntas de características demográficas e clínicas, a qual foi respondida p
Externí odkaz:
https://doaj.org/article/ed19d312d814437a890d5f54fa51eca9
Autor:
Gianluca Sottilotta, Carmelo Mangano, Rosa Basile, Carmela Falcone, Francesca Luise, Demetrio Megalizzi, Giovanna Maria Nicolò, Vincenzo Oriana, Angela Piromalli
Publikováno v:
SAGE Open Medical Case Reports, Vol 9 (2021)
Patients with COVID-19 are at high risk of thromboembolic events; for this reason, the use of heparin is largely recommended but, in addition to thrombotic complications, bleeding is a significant cause of morbidity in patients with COVID-19. Idiopat
Externí odkaz:
https://doaj.org/article/a1651e953f99422293f3633fb9fd02a8
Autor:
Annarita Tagliaferri, Angelo Claudio Molinari, Flora Peyvandi, Antonio Coppola, Francesco Demartis, Chiara Biasoli, Alessandra Borchiellini, Dorina Cultrera, Raimondo De Cristofaro, Filomena Daniele, Paola Giordano, Emanuela Marchesini, Maurizio Margaglione, Renato Marino, Berardino Pollio, Paolo Radossi, Cristina Santoro, Rita Carlotta Santoro, Sergio Siragusa, Gianluca Sottilotta, Alberto Tosetto, Lydia Piscitelli, Maria Rosaria Villa, Ezio Zanon, Adele Finardi, Irene Schiavetti, Daniella Vaccari, Giancarlo Castaman
Publikováno v:
Haemophilia. 29:135-144
Introduction: Factor IX replacement therapy is used for treatment and prophylaxis of bleeding in haemophilia B. rIX-FP is an extended half-life albumin-fusion protein, which, in clinical studies, has demonstrated prolonged dosing intervals up to 21 d
Autor:
Gianluca Sottilotta, Francesca Luise, Vincenzo Oriana, Angela Piromalli, Rosa Santacroce, Alessandra Di Lelio
Publikováno v:
Hematology Reports, Vol 11, Iss 1 (2019)
Despite many articles regarding the antihemorrhagic treatment and prophylaxis, there is a lack of experience about how to best conduct major surgical procedures in patients with congenital factor XIII (FXIII) deficiency. Here we report a case of surg
Externí odkaz:
https://doaj.org/article/c3214c7de4084157868b569a124706b7
Autor:
Ezio, Zanon, Samantha, Pasca, Gianluca, Sottilotta, Angelo C, Molinari, Antonietta, Ferretti, Patrizia, Di Gregorio, Berardino, Pollio, Michele, Pizzuti, Lucia Dora, Notarangelo, Chiara, Biasoli, Piergiorgio, Cojutti, Federico, Pea, Paolo, Simioni, Flora, Peyvandi
Publikováno v:
Blood transfusion = Trasfusione del sangue.
Congenital factor XIII (FXIII) deficiency is a rare coagulation disorder characterized by muscular or mucocutaneous bleeding with life-threatening intracranial hemorrhages (ICHs), especially in cases with severe disease. The best treatment is the use
Autor:
Ezio Zanon, Samantha Pasca, Francesco Demartis, Annarita Tagliaferri, Cristina Santoro, Isabella Cantori, Angelo Claudio Molinari, Chiara Biasoli, Antonio Coppola, Matteo Luciani, Gianluca Sottilotta, Irene Ricca, Berardino Pollio, Alessandra Borchiellini, Alberto Tosetto, Flora Peyvandi, Anna Chiara Frigo, Paolo Simioni
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 7; Pages: 1969
Background: Intracranial hemorrhage (ICH) is a highly serious event in patients with haemophilia (PWH) which leads to disability and in some cases to death. ICH occurs among all ages but is particularly frequent in newborns. Aim: The primary aim was
Autor:
Alessio Branchini, Massimo Morfini, Barbara Lunghi, Donata Belvini, Paolo Radossi, Loredana Bury, Maria Luisa Serino, Paola Giordano, Dorina Cultrera, Angelo Claudio Molinari, Mariasanta Napolitano, Elisabetta Bigagli, Giancarlo Castaman, Mirko Pinotti, Francesco Bernardi, Paola Agostini, Chiara Biasioli, Teresa Maria Caimi, Filomena Daniele, Alfredo Dragani, Donato Gemmati, Paolo Gresele, Silvia Linari, Gina Rossetti, Cristina Santoro, Rita Santoro, Gianluca Sottilotta, Johanna Svahn
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 20(1)
Background Circulating dysfunctional factor IX (FIX) might modulate distribution of infused FIX in hemophilia B (HB) patients. Recurrent substitutions at FIX activation sites (R191-R226, >300 patients) are associated with variable FIX activity and an
Autor:
Emily Oliovecchio, Pier Mannuccio Mannucci, Antonio Coppola, Elena Santagostino, Cosimo Ettorre, Giovanni Barillari, Alfonso Iorio, Annarita Tagliaferri, Lelia Valdrè, Teresa Maria Caimi, Gianluca Sottilotta, Giancarlo Castaman, Emanuela Marchesini, Isabella Cantori, Cristina Santoro, Silvia Riva, Ezio Zanon, Paolo Radossi
Publikováno v:
Haemophilia. 27
Autor:
Francesca Luise, Gianluca Sottilotta, Carmelo Mangano, Angela Piromalli, Rosa Basile, Vincenzo Oriana, Giovanna Maria Nicolò, Demetrio Megalizzi
Publikováno v:
Case Reports and Reviews. 1
Publikováno v:
Haemophilia. 27